Packaging | November 21, 2025
SOMA and Aura partner to advance innovation in on-press color correction
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
The EIR follows a product-specific Pre-Approval Inspection from September 1 to September 5, 2025.
Tagrisso plus chemotherapy achieves nearly four-year median overall survival in EGFR-mutated advanced lung cancer, setting new global standard in phase III trial
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
Combination shows consistent benefit across prespecified post-progression outcomes
The company is confident of addressing the concern raised by the USFDA
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Subscribe To Our Newsletter & Stay Updated
